OpenAlex
PricingAboutJobs
Log inGet started
Work

Intravitreal bevacizumab (Avastin) vs. ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a systematic review

HTML

Year: 2010
Type: review
Study design: Systematic Review
Source: Current Opinion in Ophthalmology
DOI: 10.1097/icu.0b013e3283386783
Authors: Christine Schmucker, Christoph Ehlken, Lutz L Hansen, Gerd Antes, Hansjuergen T Agostini, Monika Lelgemann
Institutions: University Medical Center Freiburg, University of Freiburg, University of Bremen
Language: English

Topic: Retinal Diseases and Treatments
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Keywords: bevacizumab, ranibizumab, age-related macular degeneration, intravitreal injection, anti-VEGF therapy, photodynamic therapy, visual acuity, adverse effects, off-label drug use, treatment costs, treatment interval
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2072033476
FWCI: 1.394
Cites: 56
Cited by: 49
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security